UnratedDrug recall · FDA · Published January 7, 2025
Clobazam 10mg Tablets Recall: Foreign Tablets Found in Packaging
Amerisource Health Services recalls Clobazam 10mg tablets due to foreign tablets/capsules in packaging. Affected lots: 1018598, expiring 10/31/2025. No remedy specified in recall notice.
“Clobazam 10mg Tablets Recall: Foreign Tablets Found in Packaging.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32337-clobazam-10mg-tablets-recall-foreign-tablets-found-in-packaging. Based on FDA recall #D-0201-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0201-2025%22&limit=1).
The FDA announced on Jan. 7, 2025, that Amerisource Health Services LLC voluntarily recalled Clobazam Tablets, 10 mg, distributed by Amneal Pharmaceuticals due to the presence of foreign tablets or capsules. Owners should contact the company for a refund.
How to tell if you have it
Brand: Amneal Pharmaceuticals
Product: Clobazam Tablets, 10 mg
Packaging: 30 tablets per carton (3x10 blister cards each)
NDC: 60687-423-11
Lot #: 1018598
Exp. Date: 10/31/2025
Units affected: 4,640
The hazard
The recall is due to the presence of foreign tablets or capsules in the Clobazam Tablets. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Amerisource Health Services LLC has had 30 other recalls since July 27, 2022. Recent recalls include Primidone Tablets on May 1, 2026, due to cross-contamination risk, and Meclizine 12.5mg Tablets on March 16, 2026, for failed tablet specifications. Other recent recalls of similar products include Golden State Baclofen Tablets Recall (Nov. 26, 2025) and Amgen Recalls Corlanor 5mg Tablets Due to Foreign Substance (June 4, 2026).
How to tell if you have this one
Check for lot number 1018598 on the packaging. The product is a prescription-only Clobazam 10mg tablet package with 30 tablets per carton (3x10 blister cards).
Brand
Amneal Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Packaging
Look for lot number 1018598 on the packaging to confirm if your product is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 15 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0201-2025 (January 7, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0201-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.